The price for cancers drugs is usually 3-5 peak sales at BO. Leronlimab is free of serious side effects, so it can be immediately combined with first-line chemotherapy. If we count all 6 cancers, that's hard to calculate, at least $ 20-30. The interesting thing is that Leronlimab will be approved for HIV-1 in 5-6 months and until then it will be fully known how it works in cancers, interesting situation, the off-label use of Leronlimab could be huge.